Global Therapeutic Enzyme Drugs Market Research Report 2023

Therapeutic Enzyme Drugs Market

Therapeutic Enzyme Drugs are medications that utilize enzymes to treat various medical conditions. These drugs are designed to replace deficient or malfunctioning enzymes in the body or modify biochemical processes. They can target genetic disorders, enzyme deficiencies, and other diseases by restoring normal metabolic pathways. Therapeutic enzyme drugs can be administered through injections or other delivery methods and play a vital role in managing conditions that arise from enzyme dysfunction.

According to new survey, global Therapeutic Enzyme Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Therapeutic Enzyme Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Therapeutic Enzyme Drugs Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Therapeutic Enzyme Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Injectable

1.2.3 Oral

1.2.4 Topical

1.3 Market by Application

1.3.1 Global Therapeutic Enzyme Drugs Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Gaucher Disease

1.3.3 MPS Disease

1.3.4 Gastrointestinal Diseases

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Therapeutic Enzyme Drugs Market Perspective (2018-2029)

2.2 Therapeutic Enzyme Drugs Growth Trends by Region

2.2.1 Global Therapeutic Enzyme Drugs Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Therapeutic Enzyme Drugs Historic Market Size by Region (2018-2023)

2.2.3 Therapeutic Enzyme Drugs Forecasted Market Size by Region (2024-2029)

2.3 Therapeutic Enzyme Drugs Market Dynamics

2.3.1 Therapeutic Enzyme Drugs Industry Trends

2.3.2 Therapeutic Enzyme Drugs Market Drivers

2.3.3 Therapeutic Enzyme Drugs Market Challenges

2.3.4 Therapeutic Enzyme Drugs Market Restraints

3.1 Global Top Therapeutic Enzyme Drugs Players by Revenue

3.1.1 Global Top Therapeutic Enzyme Drugs Players by Revenue (2018-2023)

3.1.2 Global Therapeutic Enzyme Drugs Revenue Market Share by Players (2018-2023)

3.2 Global Therapeutic Enzyme Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Therapeutic Enzyme Drugs Revenue

3.4 Global Therapeutic Enzyme Drugs Market Concentration Ratio

3.4.1 Global Therapeutic Enzyme Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Enzyme Drugs Revenue in 2022

3.5 Therapeutic Enzyme Drugs Key Players Head office and Area Served

3.6 Key Players Therapeutic Enzyme Drugs Product Solution and Service

3.7 Date of Enter into Therapeutic Enzyme Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Therapeutic Enzyme Drugs Historic Market Size by Type (2018-2023)

4.2 Global Therapeutic Enzyme Drugs Forecasted Market Size by Type (2024-2029)

5.1 Global Therapeutic Enzyme Drugs Historic Market Size by Application (2018-2023)

5.2 Global Therapeutic Enzyme Drugs Forecasted Market Size by Application (2024-2029)

6.1 North America Therapeutic Enzyme Drugs Market Size (2018-2029)

6.2 North America Therapeutic Enzyme Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Therapeutic Enzyme Drugs Market Size by Country (2018-2023)

6.4 North America Therapeutic Enzyme Drugs Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Therapeutic Enzyme Drugs Market Size (2018-2029)

7.2 Europe Therapeutic Enzyme Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Therapeutic Enzyme Drugs Market Size by Country (2018-2023)

7.4 Europe Therapeutic Enzyme Drugs Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Therapeutic Enzyme Drugs Market Size (2018-2029)

8.2 Asia-Pacific Therapeutic Enzyme Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2018-2023)

8.4 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Therapeutic Enzyme Drugs Market Size (2018-2029)

9.2 Latin America Therapeutic Enzyme Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Therapeutic Enzyme Drugs Market Size by Country (2018-2023)

9.4 Latin America Therapeutic Enzyme Drugs Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Therapeutic Enzyme Drugs Market Size (2018-2029)

10.2 Middle East & Africa Therapeutic Enzyme Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2018-2023)

10.4 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Sanofi

11.1.1 Sanofi Company Detail

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Therapeutic Enzyme Drugs Introduction

11.1.4 Sanofi Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.1.5 Sanofi Recent Development

11.2 BioMarin

11.2.1 BioMarin Company Detail

11.2.2 BioMarin Business Overview

11.2.3 BioMarin Therapeutic Enzyme Drugs Introduction

11.2.4 BioMarin Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.2.5 BioMarin Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Detail

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Therapeutic Enzyme Drugs Introduction

11.3.4 AbbVie Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.3.5 AbbVie Recent Development

11.4 Shire

11.4.1 Shire Company Detail

11.4.2 Shire Business Overview

11.4.3 Shire Therapeutic Enzyme Drugs Introduction

11.4.4 Shire Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.4.5 Shire Recent Development

11.5 Alexion

11.5.1 Alexion Company Detail

11.5.2 Alexion Business Overview

11.5.3 Alexion Therapeutic Enzyme Drugs Introduction

11.5.4 Alexion Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.5.5 Alexion Recent Development

11.6 Horizon Pharma

11.6.1 Horizon Pharma Company Detail

11.6.2 Horizon Pharma Business Overview

11.6.3 Horizon Pharma Therapeutic Enzyme Drugs Introduction

11.6.4 Horizon Pharma Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.6.5 Horizon Pharma Recent Development

11.7 Allergan

11.7.1 Allergan Company Detail

11.7.2 Allergan Business Overview

11.7.3 Allergan Therapeutic Enzyme Drugs Introduction

11.7.4 Allergan Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.7.5 Allergan Recent Development

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Detail

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Therapeutic Enzyme Drugs Introduction

11.8.4 Johnson & Johnson Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.8.5 Johnson & Johnson Recent Development

11.9 Recordati Rare Diseases

11.9.1 Recordati Rare Diseases Company Detail

11.9.2 Recordati Rare Diseases Business Overview

11.9.3 Recordati Rare Diseases Therapeutic Enzyme Drugs Introduction

11.9.4 Recordati Rare Diseases Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.9.5 Recordati Rare Diseases Recent Development

11.10 Pfizer

11.10.1 Pfizer Company Detail

11.10.2 Pfizer Business Overview

11.10.3 Pfizer Therapeutic Enzyme Drugs Introduction

11.10.4 Pfizer Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.10.5 Pfizer Recent Development

11.11 Vivus

11.11.1 Vivus Company Detail

11.11.2 Vivus Business Overview

11.11.3 Vivus Therapeutic Enzyme Drugs Introduction

11.11.4 Vivus Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.11.5 Vivus Recent Development

11.12 Digestive Care

11.12.1 Digestive Care Company Detail

11.12.2 Digestive Care Business Overview

11.12.3 Digestive Care Therapeutic Enzyme Drugs Introduction

11.12.4 Digestive Care Revenue in Therapeutic Enzyme Drugs Business (2018-2023)

11.12.5 Digestive Care Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Therapeutic Enzyme Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Injectable

    Table 3. Key Players of Oral

    Table 4. Key Players of Topical

    Table 5. Global Therapeutic Enzyme Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Therapeutic Enzyme Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Therapeutic Enzyme Drugs Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Therapeutic Enzyme Drugs Market Share by Region (2018-2023)

    Table 9. Global Therapeutic Enzyme Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Therapeutic Enzyme Drugs Market Share by Region (2024-2029)

    Table 11. Therapeutic Enzyme Drugs Market Trends

    Table 12. Therapeutic Enzyme Drugs Market Drivers

    Table 13. Therapeutic Enzyme Drugs Market Challenges

    Table 14. Therapeutic Enzyme Drugs Market Restraints

    Table 15. Global Therapeutic Enzyme Drugs Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Therapeutic Enzyme Drugs Market Share by Players (2018-2023)

    Table 17. Global Top Therapeutic Enzyme Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Enzyme Drugs as of 2022)

    Table 18. Ranking of Global Top Therapeutic Enzyme Drugs Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Therapeutic Enzyme Drugs Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Therapeutic Enzyme Drugs Product Solution and Service

    Table 22. Date of Enter into Therapeutic Enzyme Drugs Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Therapeutic Enzyme Drugs Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2018-2023)

    Table 26. Global Therapeutic Enzyme Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2024-2029)

    Table 28. Global Therapeutic Enzyme Drugs Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Therapeutic Enzyme Drugs Revenue Market Share by Application (2018-2023)

    Table 30. Global Therapeutic Enzyme Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Therapeutic Enzyme Drugs Revenue Market Share by Application (2024-2029)

    Table 32. North America Therapeutic Enzyme Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Therapeutic Enzyme Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Therapeutic Enzyme Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Therapeutic Enzyme Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Therapeutic Enzyme Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Therapeutic Enzyme Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Therapeutic Enzyme Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Therapeutic Enzyme Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Therapeutic Enzyme Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Therapeutic Enzyme Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Therapeutic Enzyme Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Sanofi Company Detail

    Table 48. Sanofi Business Overview

    Table 49. Sanofi Therapeutic Enzyme Drugs Product

    Table 50. Sanofi Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 51. Sanofi Recent Development

    Table 52. BioMarin Company Detail

    Table 53. BioMarin Business Overview

    Table 54. BioMarin Therapeutic Enzyme Drugs Product

    Table 55. BioMarin Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 56. BioMarin Recent Development

    Table 57. AbbVie Company Detail

    Table 58. AbbVie Business Overview

    Table 59. AbbVie Therapeutic Enzyme Drugs Product

    Table 60. AbbVie Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 61. AbbVie Recent Development

    Table 62. Shire Company Detail

    Table 63. Shire Business Overview

    Table 64. Shire Therapeutic Enzyme Drugs Product

    Table 65. Shire Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 66. Shire Recent Development

    Table 67. Alexion Company Detail

    Table 68. Alexion Business Overview

    Table 69. Alexion Therapeutic Enzyme Drugs Product

    Table 70. Alexion Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 71. Alexion Recent Development

    Table 72. Horizon Pharma Company Detail

    Table 73. Horizon Pharma Business Overview

    Table 74. Horizon Pharma Therapeutic Enzyme Drugs Product

    Table 75. Horizon Pharma Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 76. Horizon Pharma Recent Development

    Table 77. Allergan Company Detail

    Table 78. Allergan Business Overview

    Table 79. Allergan Therapeutic Enzyme Drugs Product

    Table 80. Allergan Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 81. Allergan Recent Development

    Table 82. Johnson & Johnson Company Detail

    Table 83. Johnson & Johnson Business Overview

    Table 84. Johnson & Johnson Therapeutic Enzyme Drugs Product

    Table 85. Johnson & Johnson Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 86. Johnson & Johnson Recent Development

    Table 87. Recordati Rare Diseases Company Detail

    Table 88. Recordati Rare Diseases Business Overview

    Table 89. Recordati Rare Diseases Therapeutic Enzyme Drugs Product

    Table 90. Recordati Rare Diseases Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 91. Recordati Rare Diseases Recent Development

    Table 92. Pfizer Company Detail

    Table 93. Pfizer Business Overview

    Table 94. Pfizer Therapeutic Enzyme Drugs Product

    Table 95. Pfizer Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 96. Pfizer Recent Development

    Table 97. Vivus Company Detail

    Table 98. Vivus Business Overview

    Table 99. Vivus Therapeutic Enzyme Drugs Product

    Table 100. Vivus Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 101. Vivus Recent Development

    Table 102. Digestive Care Company Detail

    Table 103. Digestive Care Business Overview

    Table 104. Digestive Care Therapeutic Enzyme Drugs Product

    Table 105. Digestive Care Revenue in Therapeutic Enzyme Drugs Business (2018-2023) & (US$ Million)

    Table 106. Digestive Care Recent Development

    Table 107. Research Programs/Design for This Report

    Table 108. Key Data Information from Secondary Sources

    Table 109. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Therapeutic Enzyme Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Therapeutic Enzyme Drugs Market Share by Type: 2022 VS 2029

    Figure 3. Injectable Features

    Figure 4. Oral Features

    Figure 5. Topical Features

    Figure 6. Global Therapeutic Enzyme Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Therapeutic Enzyme Drugs Market Share by Application: 2022 VS 2029

    Figure 8. Gaucher Disease Case Studies

    Figure 9. MPS Disease Case Studies

    Figure 10. Gastrointestinal Diseases Case Studies

    Figure 11. Others Case Studies

    Figure 12. Therapeutic Enzyme Drugs Report Years Considered

    Figure 13. Global Therapeutic Enzyme Drugs Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Therapeutic Enzyme Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Therapeutic Enzyme Drugs Market Share by Region: 2022 VS 2029

    Figure 16. Global Therapeutic Enzyme Drugs Market Share by Players in 2022

    Figure 17. Global Top Therapeutic Enzyme Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Enzyme Drugs as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Therapeutic Enzyme Drugs Revenue in 2022

    Figure 19. North America Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Therapeutic Enzyme Drugs Market Share by Country (2018-2029)

    Figure 21. United States Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Therapeutic Enzyme Drugs Market Share by Country (2018-2029)

    Figure 25. Germany Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Therapeutic Enzyme Drugs Market Share by Region (2018-2029)

    Figure 33. China Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Therapeutic Enzyme Drugs Market Share by Country (2018-2029)

    Figure 41. Mexico Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Therapeutic Enzyme Drugs Market Share by Country (2018-2029)

    Figure 45. Turkey Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Therapeutic Enzyme Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Sanofi Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 48. BioMarin Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 49. AbbVie Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 50. Shire Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 51. Alexion Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 52. Horizon Pharma Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 53. Allergan Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 54. Johnson & Johnson Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 55. Recordati Rare Diseases Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 56. Pfizer Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 57. Vivus Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 58. Digestive Care Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2018-2023)

    Figure 59. Bottom-up and Top-down Approaches for This Report

    Figure 60. Data Triangulation

    Figure 61. Key Executives Interviewed